Peter M Palese

USPTO Granted Patents = 83 (Patent Applications = 33)

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 2.9

ph-index = 23

Forward Citations = 2,055(Granted Patents)

Forward Citations (Not Self Cited) = 1,216(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Leoma, NJ (US) (2005)
Leonis, NJ (US) (2005)
Loonta, NJ (US) (2015)
Leonia, NJ (US) (1992 - 2017)
New York, NY (US) (2014 - 2024)

Company Filing History:

37 out of 270

Icahn School of Medicine at Mount Sinai

patents

34 out of 242

Mount Sinai School of Medicine

patents

5 out of 260

St. Jude Children's Research Hospital

patents

4. 5 out of 1,195

United States of America, As Represented by the Secretary of Agriculture

patents

5. 5 out of 560

Memorial Sloan Kettering Cancer Center

Medimmune Vaccines, Inc.

patents

8. 2 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

9. 1 out of 18

Worcester Foundation for Experimental Biology

patents

10. 1 out of 4

The Mount Sinai Medical Center

patents

11. 1 out of 881

University of Kentucky Research Foundation

patents

12. 1 out of 576

The Salk Institute for Biological Studies

patents

13. 1 out of 99

Sanford-burnham Medical Research Institute

patents

14. 7 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2025

Loading Chart...

Areas of Expertise:

Influenza Virus Vaccines

Chimeric Viruses

Genetically Engineered Viruses

Monoclonal Antibodies

Antiviral Compounds

Hemagglutinin Proteins

Newcastle Disease Viruses

Negative Strand Viruses

Viral Replication Inhibition

Recombinant Virus Systems

Vaccination Regimens

Interferon Antagonist Activity

83 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12233123 - Influenza virus hemagglutinin proteins and uses thereof (2025-02-25),

2. 12042534 - Newcastle disease viruses and uses thereof (2024-07-23),

3. 12030928 - Anti-influenza B virus neuraminidase antibodies and uses thereof (2024-07-09),

4. 11865173 - Influenza virus hemagglutinin proteins and uses thereof (2024-01-09),

5. 11266734 - Influenza virus hemagglutinin proteins and uses thereof (2022-03-08),

6. 11254733 - Anti-influenza B virus neuraminidase antibodies and uses thereof (2022-02-22),

7. 10736956 - Influenza virus vaccination regimens (2020-08-11),

8. 10583188 - Influenza virus vaccines and uses thereof (2020-03-10),

9. 10544207 - Antibodies against influenza virus hemagglutinin and uses thereof (2020-01-28),

10. 10543268 - Genetically engineered swine influenza virus and uses thereof (2020-01-28),

11. 10308913 - Chimeric viruses presenting non-native surface proteins and uses thereof (2019-06-04),

12. 10251922 - Newcastle disease viruses and uses thereof (2019-04-09),

13. 10179806 - Influenza virus vaccines and uses thereof (2019-01-15),

14. 10137189 - Influenza virus vaccines and uses thereof (2018-11-27),

15. 10131695 - Influenza virus vaccines and uses thereof (2018-11-20),

Title: The Innovative Journey of Peter M. Palese

Introduction: Peter M. Palese, a distinguished male inventor hailing from Leonia, NJ (US), has made significant contributions to the field of innovations and inventions.

Latest Patents: Peter M. Palese holds several patents in the field of biotechnology and medical research, focusing on novel approaches to combating infectious diseases.

Career Highlights: With a career spanning several decades, Peter M. Palese has been at the forefront of groundbreaking research in virology, particularly in the development of vaccines and antiviral therapies.

Collaborations: Throughout his career, Peter M. Palese has collaborated with leading scientists, research institutions, and pharmaceutical companies to advance the field of virology and infectious disease research.

Conclusion: Peter M. Palese's dedication to innovation and his pioneering work in virology have significantly impacted the scientific community, making him a respected figure in the world of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.